Related Experiment Video
Updated: Feb 12, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Targeted Therapy and Immunotherapy in the Treatment of Non-Small Cell Lung Cancer
Girish S Shroff1, Patricia M de Groot1, Vassiliki A Papadimitrakopoulou2
1Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Abstract:
The treatment strategy in advanced non-small cell lung cancer (NSCLC) has evolved from empirical chemotherapy to a personalized approach based on histology and molecular markers of primary tumors. Targeted therapies are directed at the products of oncogenic driver mutations. Immunotherapy facilitates the recognition of cancer as foreign by the host immune system, stimulates the immune system, and alleviates the inhibition that allows the growth and spread of cancer cells. The authors describes the role of targeted therapy and immunotherapy in the treatment of NSCLC, patterns of disease present on imaging studies, and immune-related adverse events encountered with immunotherapy.
Insights
Advanced non-small cell lung cancer (NSCLC) treatment now uses targeted therapy and immunotherapy. These approaches personalize care by targeting mutations and stimulating the immune system to fight cancer effectively.
Area of Science:
- Oncology
- Immunology
- Radiology
Background:
- Treatment for advanced non-small cell lung cancer (NSCLC) has shifted from chemotherapy to personalized medicine.
- This personalized approach utilizes histology and molecular markers from primary tumors.
- Key advancements include targeted therapies and immunotherapies.
Purpose of the Study:
- To review the roles of targeted therapy and immunotherapy in treating NSCLC.
- To describe imaging patterns associated with these advanced treatments.
- To outline immune-related adverse events linked to immunotherapy.
Main Methods:
- Literature review and synthesis of current research on NSCLC treatments.
- Analysis of imaging findings related to targeted therapy and immunotherapy efficacy.
- Compilation of data on immune-related adverse events.
Main Results:
- Targeted therapies focus on oncogenic driver mutations.
- Immunotherapy enhances the host immune system's ability to recognize and attack cancer cells.
- Imaging plays a crucial role in monitoring treatment response and disease patterns.
Conclusions:
- Personalized medicine, including targeted therapy and immunotherapy, represents a significant evolution in NSCLC management.
- Understanding imaging patterns and potential immune-related adverse events is essential for optimal patient care.
More Related Videos
05:17Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Tumor Immunotherapy
Gene Therapy
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...